{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:52:22Z","timestamp":1772027542478,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s12029-021-00717-8","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:03:36Z","timestamp":1643241816000},"page":"126-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["RETRACTED ARTICLE: Angiotensin II Receptor Antagonist, Valsartan, Has Beneficial Effect in Lung Metastasis of Colorectal Cancer Treated with Fluorouracil"],"prefix":"10.1007","volume":"54","author":[{"given":"Fereshteh","family":"Asgharzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloufar","family":"Naghibzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milad","family":"Hashemzehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Mostafapour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mahdi","family":"Hassanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Avan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"717_CR1","doi-asserted-by":"crossref","unstructured":"Stella GM, Kolling S, Benvenuti S, Bortolotto C. Lung-seeking metastases. Cancers. 2019;11(7):1010-1018.","DOI":"10.3390\/cancers11071010"},{"issue":"1","key":"717_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1758834010388342","volume":"3","author":"MS Braun","year":"2011","unstructured":"Braun MS, Seymour MT. Balancing the efficacy and toxicity of chemotherapy in colorectal cancer. Ther Adv Med Oncol. 2011;3(1):43\u201352.","journal-title":"Ther Adv Med Oncol"},{"issue":"12","key":"717_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5306\/wjco.v3.i12.150","volume":"3","author":"H Kuniyasu","year":"2012","unstructured":"Kuniyasu H. Multiple roles of angiotensin in colorectal cancer. World J Clin Oncol. 2012;3(12):150\u20134.","journal-title":"World J Clin Oncol"},{"issue":"2","key":"717_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.canlet.2012.10.006","volume":"328","author":"X Chen","year":"2013","unstructured":"Chen X, Meng Q, Zhao Y, Liu M, Li D, Yang Y, et al. Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer. Cancer Lett. 2013;328(2):318\u201324.","journal-title":"Cancer Lett"},{"issue":"6","key":"717_CR5","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3892\/ijo_00000287","volume":"34","author":"J Kinoshita","year":"2009","unstructured":"Kinoshita J, Fushida S, Harada S, Yagi Y, Fujita H, Kinami S, et al. Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1\/2, NF-\u03baB and survivin. Int J Oncol. 2009;34(6):1573\u201382.","journal-title":"Int J Oncol"},{"issue":"4","key":"717_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10585-014-9635-8","volume":"31","author":"SL Koh","year":"2014","unstructured":"Koh SL, Ager E, Costa P, Malcontenti-Wilson C, Muralidharan V, Christophi C. Blockade of the renin\u2013angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver. Clin Exp Metas. 2014;31(4):395\u2013405.","journal-title":"Clin Exp Metas"},{"issue":"2","key":"717_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ajpath.2012.10.026","volume":"182","author":"H Amano","year":"2013","unstructured":"Amano H, Ito Y, Ogawa F, Eshima K, Suzuki T, Oba K, et al. Angiotensin II type 1A receptor signaling facilitates tumor metastasis formation through P-selectin\u2013mediated interaction of tumor cells with platelets and endothelial cells. Am J Pathol. 2013;182(2):553\u201364.","journal-title":"Am J Pathol"},{"key":"717_CR8","first-page":"29","volume":"8","author":"R Yacoub","year":"2015","unstructured":"Yacoub R, Campbell KN. Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renovasc Dis. 2015;8:29\u201340.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"3","key":"717_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1001\/archinte.160.3.349","volume":"160","author":"CR Meier","year":"2000","unstructured":"Meier CR, Derby LE, Jick SS, Jick H. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med. 2000;160(3):349\u201353.","journal-title":"Arch Intern Med"},{"issue":"11","key":"717_CR10","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/sj.bjc.6605955","volume":"103","author":"Y Nakai","year":"2010","unstructured":"Nakai Y, Isayama H, Ijichi H, Sasaki T, Sasahira N, Hirano K, et al. Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. Br J Cancer. 2010;103(11):1644\u20138.","journal-title":"Br J Cancer"},{"issue":"2","key":"717_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/MPA.0b013e31825de678","volume":"42","author":"Y Nakai","year":"2013","unstructured":"Nakai Y, Isayama H, Sasaki T, Mizuno S, Sasahira N, Kogure H, et al. Clinical outcomes of chemotherapy for diabetic and nondiabetic patients with pancreatic cancer: better prognosis with statin use in diabetic patients. Pancreas. 2013;42(2):202\u20138.","journal-title":"Pancreas"},{"key":"717_CR12","doi-asserted-by":"crossref","unstructured":"Osumi H, Matsusaka S, Suenaga M, Wakatsuki T, Kumekawa Y, Ogura M, et al. Angiotensin II receptor blocker (ARB) may have a synergic effect in metastatic colorectal cancer (MCRC) patients treated with bevacizumab (BEV). Ann Oncol 2013; 24:iv34.","DOI":"10.1093\/annonc\/mdt202.26"},{"issue":"1","key":"717_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/sj.bjc.6604431","volume":"99","author":"O Arrieta","year":"2008","unstructured":"Arrieta O, Pineda-Olvera B, Guevara-Salazar P, Hern\u00e1ndez-Pedro N, Morales-Espinosa D, Cer\u00f3n-Lizarraga TL, et al. Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis. Br J Cancer. 2008;99(1):160\u20136.","journal-title":"Br J Cancer"},{"issue":"7","key":"717_CR14","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1007\/s13277-015-3235-3","volume":"36","author":"O Arrieta","year":"2015","unstructured":"Arrieta O, Villarreal-Garza C, Vizca\u00edno G, Pineda B, Hern\u00e1ndez-Pedro N, Guevara-Salazar P, et al. Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer. Tumour Biol. 2015;36(7):5627\u201334.","journal-title":"Tumour Biol"},{"issue":"10","key":"717_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.clinre.2011.06.008","volume":"35","author":"Y Beyazit","year":"2011","unstructured":"Beyazit Y, Purnak T, Suvak B, Kurt M, Sayilir A, Turhan T, et al. Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms. Clin Res Hepatol Gastroenterol. 2011;35(10):644\u20139.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"717_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrneph.2013.251","volume":"10","author":"SS Roscioni","year":"2014","unstructured":"Roscioni SS, Heerspink HJ, de Zeeuw D. The effect of RAAS blockade on the progression of diabetic nephropathy. Nat Rev Nephrol. 2014;10(2):77\u201387.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"717_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0006-291X(02)00496-5","volume":"294","author":"M Fujita","year":"2002","unstructured":"Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun. 2002;294(2):441\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"717_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1440-1746.2006.04797.x","volume":"22","author":"JH Neo","year":"2007","unstructured":"Neo JH, Malcontenti-Wilson C, Muralidharan V, Christophi C. Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases. J Gastroenterol Hepatol. 2007;22(4):577\u201384.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"717_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","volume":"12","author":"S Bangalore","year":"2011","unstructured":"Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials. Lancet Oncol. 2011;12(1):65\u201382.","journal-title":"Lancet Oncol"},{"issue":"9426","key":"717_CR20","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","volume":"363","author":"S Julius","year":"2004","unstructured":"Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363(9426):2022\u201331.","journal-title":"Lancet"},{"issue":"12","key":"717_CR21","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","volume":"359","author":"S Yusuf","year":"2008","unstructured":"Yusuf S, Diener H-C, Sacco RL, Cotton D, \u00d4unpuu S, Lawton WA, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008;359(12):1225\u201337.","journal-title":"N Engl J Med"},{"key":"717_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bcp.2018.04.012","volume":"154","author":"S Ishikane","year":"2018","unstructured":"Ishikane S, Hosoda H, Nojiri T, Tokudome T, Mizutani T, Miura K, et al. Angiotensin II promotes pulmonary metastasis of melanoma through the activation of adhesion molecules in vascular endothelial cells. Biochem Pharmacol. 2018;154:136\u201347.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"717_CR23","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1007\/s11605-010-1347-z","volume":"14","author":"J DiNorcia","year":"2010","unstructured":"DiNorcia J, Moroziewicz DN, Ippagunta N, Lee MK, Foster M, Rotterdam HZ, et al. RAGE signaling significantly impacts tumorigenesis and hepatic tumor growth in murine models of colorectal carcinoma. J Gastrointest Surg. 2010;14(11):1680\u201390.","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"717_CR24","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3892\/or.2017.5954","volume":"38","author":"Y Li","year":"2017","unstructured":"Li Y, Wang C, Li D, Deng P, Shao X, Hu J, et al. 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice. Oncol Rep. 2017;38(5):3044\u201354.","journal-title":"Oncol Rep"},{"key":"717_CR25","doi-asserted-by":"crossref","unstructured":"Lee B-R, Islam MT, Park S-H, Jung H-i, Bae D-W, Kim T-H. Characterization of salicylic acid-mediated modulation of the drought stress responses: reactive oxygen species, proline, and redox state in Brassica napus. Environ Exp Bot 2019; 157:1\u201310.","DOI":"10.1016\/j.envexpbot.2018.09.013"},{"key":"717_CR26","first-page":"927","volume":"19","author":"M Hashemzehi","year":"2020","unstructured":"Hashemzehi M, Naghibzadeh N, Asgharzadeh F, Mostafapour A, Hassanian SM, Ferns GA, et al. The therapeutic potential of losartan in lung metastasis of colorectal cancer. EXCLI J. 2020;19:927\u201335.","journal-title":"EXCLI J"},{"issue":"7","key":"717_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/emmm.201000080","volume":"2","author":"A Benigni","year":"2010","unstructured":"Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med. 2010;2(7):247\u201357.","journal-title":"EMBO Mol Med"},{"issue":"10","key":"717_CR28","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nri2634","volume":"9","author":"R Medzhitov","year":"2009","unstructured":"Medzhitov R, Horng T. Transcriptional control of the inflammatory response. Nat Rev Immunol. 2009;9(10):692\u2013703.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"717_CR29","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.amjhyper.2005.09.022","volume":"19","author":"H Kitayama","year":"2006","unstructured":"Kitayama H, Maeshima Y, Takazawa Y, Yamamoto Y, Wu Y, Ichinose K, et al. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries. Am J Hypertens. 2006;19(7):718\u201327.","journal-title":"Am J Hypertens"},{"key":"717_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.biopha.2018.01.117","volume":"99","author":"E Ahmadian","year":"2018","unstructured":"Ahmadian E, Khosroushahi AY, Eftekhari A, Farajnia S, Babaei H, Eghbal MA. Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2. Biomed Pharmacother. 2018;99:939\u201346.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"717_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbrc.2009.01.035","volume":"380","author":"J Lv","year":"2009","unstructured":"Lv J, Jia R, Yang D, Zhu J, Ding G. Candesartan attenuates angiotensin II-induced mesangial cell apoptosis via TLR4\/MyD88 pathway. Biochem Biophys Res Commun. 2009;380(1):81\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"717_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.immuni.2012.10.015","volume":"38","author":"V Cortez-Retamozo","year":"2013","unstructured":"Cortez-Retamozo V, Etzrodt M, Newton A, Ryan R, Pucci F, Sio SW, et al. Angiotensin II drives the production of tumor-promoting macrophages. Immunity. 2013;38(2):296\u2013308.","journal-title":"Immunity"},{"issue":"6","key":"717_CR33","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3892\/mco.2015.630","volume":"3","author":"H Osumi","year":"2015","unstructured":"Osumi H, Matsusaka S, Wakatsuki T, Suenaga M, Shinozaki E, Mizunuma N. Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients. Mol Clin Oncol. 2015;3(6):1295\u2013300.","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"717_CR34","first-page":"593","volume":"23","author":"T Ohta","year":"2003","unstructured":"Ohta T, Amaya K, Yi S, Kitagawa H, Kayahara M, Ninomiya I, et al. Angiotensin converting enzyme-independent, local angiotensin II-generation in human pancreatic ductal cancer tissues. Int J Oncol. 2003;23(3):593\u20138.","journal-title":"Int J Oncol"},{"issue":"5","key":"717_CR35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/gut.2009.188961","volume":"59","author":"V Fendrich","year":"2010","unstructured":"Fendrich V, Chen NM, Neef M, Waldmann J, Buchholz M, Feldmann G, et al. The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer. Gut. 2010;59(5):630\u20137.","journal-title":"Gut"},{"issue":"3","key":"717_CR36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.urology.2008.10.031","volume":"73","author":"M Kosugi","year":"2009","unstructured":"Kosugi M, Miyajima A, Kikuchi E, Kosaka T, Horiguchi Y, Murai M, et al. Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancer. Urology. 2009;73(3):655\u201360.","journal-title":"Urology"},{"issue":"2","key":"717_CR37","first-page":"441","volume":"17","author":"K Yanase","year":"2007","unstructured":"Yanase K, Yoshiji H, Ikenaka Y, Noguchi R, Kitade M, Kaji K, et al. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities. Oncol Rep. 2007;17(2):441\u20136.","journal-title":"Oncol Rep"},{"issue":"2","key":"717_CR38","first-page":"355","volume":"22","author":"R Noguchi","year":"2009","unstructured":"Noguchi R, Yoshiji H, Ikenaka Y, Namisaki T, Kitade M, Kaji K, et al. Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growth via anti-angiogenic activities. Oncol Rep. 2009;22(2):355\u201360.","journal-title":"Oncol Rep"},{"issue":"4","key":"717_CR39","first-page":"849","volume":"25","author":"K Amaya","year":"2004","unstructured":"Amaya K, Ohta T, Kitagawa H, Kayahara M, Takamura H, Fujimura T, et al. Angiotensin II activates MAP kinase and NF-kappaB through angiotensin II type I receptor in human pancreatic cancer cells. Int J Oncol. 2004;25(4):849\u201356.","journal-title":"Int J Oncol"},{"issue":"5","key":"717_CR40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/MPA.0b013e3181c314cd","volume":"39","author":"Q Gong","year":"2010","unstructured":"Gong Q, Davis M, Chipitsyna G, Yeo CJ, Arafat HA. Blocking angiotensin II type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells. Pancreas. 2010;39(5):581\u201394.","journal-title":"Pancreas"}],"updated-by":[{"DOI":"10.1007\/s12029-025-01221-z","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000}}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-021-00717-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-021-00717-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-021-00717-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T01:02:49Z","timestamp":1744246969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-021-00717-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1007\/s12029-021-00717-8","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"20 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12029-025-01221-z","URL":"https:\/\/doi.org\/10.1007\/s12029-025-01221-z","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the experiments were conducted in accordance with Mashhad University of Medical Science guidelines for animal experiments, and the Local Committee for Experiments with Laboratory Animals in Mashhad, Iran, gave their approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors are aware of and agree to the content of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}